Management of failing bidirectional cavopulmonary shunt: Influence of additional systemic-to-pulmonary-artery shunt with classic Glenn physiology.
AVV, atrioventricular valve
BCPS, bidirectional cavopulmonary shunt
CPB, cardiopulmonary bypass
ECMO, extracorporeal membrane oxygenation
HLHS, hypoplastic left heart syndrome
PA, pulmonary artery
PAP, pulmonary artery pressure
PVO, pulmonary venous obstruction
SVC, superior vena cava
TCPC, total cavopulmonary connection
VF, ventricular function
additional systemic-to-pulmonary-artery shunt
bidirectional cavopulmonary shunt
cyanosis
pulmonary artery hypoplasia
pulmonary venous obstruction
takedown
Journal
JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
04
01
2022
accepted:
03
06
2022
entrez:
29
9
2022
pubmed:
30
9
2022
medline:
30
9
2022
Statut:
epublish
Résumé
Severe hypoxemia in the early postoperative period after bidirectional cavopulmonary shunt (BCPS) is a critical complication. We aimed to evaluate patients who underwent additional systemic to pulmonary shunt and septation of central pulmonary artery (partial takedown) after BCPS. The medical records of all patients who underwent BCPS between 2007 and 2020 were reviewed. Patients who underwent partial takedown were extracted and their outcomes were analyzed. Of 441 BCPS patients, 27 patients (6%) required partial takedown. Most frequent diagnosis was hypoplastic left heart syndrome (n = 14; 52%). Additional complicating factors included pulmonary artery hypoplasia (n = 12) and pulmonary venous obstruction (n = 3). Thirteen patients (48%) underwent partial takedown on the same day of BCPS, and all of them survived the procedure. The remaining 14 patients (52%) underwent partial takedown between postoperative 1 to 64 days. The reasons for partial takedown were: postoperative high pulmonary vascular resistance (n = 4), early BCPS (<90 days) with PA hypoplasia (n = 3), mediastinitis/pneumonia (n = 3), pulmonary venous obstruction (n = 2), ventricular dysfunction (n = 1), and recurrent pneumothorax (n = 1). Four patients experienced hospital deaths. Six patients died after discharge, 10 achieved Fontan completion, and 6 were alive and waiting for Fontan. Overall survival after partial takedown was 54% at 3 years. The pulmonary venous obstruction ( The partial takedown resulted in a 3-year survival rate of more than 50%. Of these patients, a significant number underwent successful Fontan completion who would exhibit potential early death with conservative treatment.
Identifiants
pubmed: 36172411
doi: 10.1016/j.xjon.2022.06.007
pii: S2666-2736(22)00278-9
pmc: PMC9510880
doi:
Types de publication
Journal Article
Langues
eng
Pagination
373-387Informations de copyright
© 2022 The Author(s).
Références
Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):669-679
pubmed: 33691189
Eur J Cardiothorac Surg. 2010 Jul;38(1):59-65
pubmed: 20206539
J Thorac Cardiovasc Surg. 2007 Jul;134(1):82-9, 89.e1-2
pubmed: 17599490
Ann Thorac Surg. 2018 Jul;106(1):156-164
pubmed: 29653081
Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):182-188
pubmed: 29428622
Interact Cardiovasc Thorac Surg. 2021 Jun 28;33(1):124-130
pubmed: 33738489
Ann Thorac Surg. 2012 Feb;93(2):614-8; discussion 619
pubmed: 22197533
Am J Cardiol. 1995 May 15;75(15):1048-50
pubmed: 7747687
Ann Thorac Surg. 2021 Aug;112(2):610-618
pubmed: 32828751
Interact Cardiovasc Thorac Surg. 2007 Apr;6(2):150-4
pubmed: 17669796
Ann Thorac Surg. 1998 Aug;66(2):664-7
pubmed: 9725449
Eur J Cardiothorac Surg. 2012 Jul;42(1):42-8; discussion 48-9
pubmed: 22290923
World J Pediatr Congenit Heart Surg. 2021 Nov;12(6):760-764
pubmed: 34846973
World J Pediatr Congenit Heart Surg. 2013 Oct;4(4):367-72
pubmed: 24327629
Interact Cardiovasc Thorac Surg. 2007 Feb;6(1):97-101
pubmed: 17669781
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):177-185
pubmed: 32053189
Eur J Cardiothorac Surg. 2016 Jan;49(1):183-7
pubmed: 25769466
J Thorac Cardiovasc Surg. 2018 Feb;155(2):701-709.e6
pubmed: 28992972
Eur J Cardiothorac Surg. 2008 Sep;34(3):550-4 ;discussion 554-5
pubmed: 18534863
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35445711
J Card Surg. 2015 Sep;30(9):724-30
pubmed: 26138594
J Thorac Cardiovasc Surg. 2015 Mar;149(3):699-705
pubmed: 25454920
J Thorac Cardiovasc Surg. 2021 Apr;161(4):e321-e322
pubmed: 33189342
J Thorac Cardiovasc Surg. 2020 Dec;160(6):1529-1540.e4
pubmed: 32595030